Journal of Public Health Policy and Planning

Reach Us +1-845-458-6882

Commentary - Journal of Public Health Policy and Planning (2021) Volume 5, Issue 8

An overview on human intestinal Bifidobacterium as probiotics.

Mia Noah*

Department of Applied Science, Delft University of Technology, Delft, Netherlands

*Correspondence to:

Mia Noah

Department of Applied Science

Delft University of Technology



E-Mail:- [email protected]

Accepted on August 04, 2021

Visit for more related articles at Journal of Public Health Policy and Planning


Bifidobacterium is a variety of gram-positive, nonmotile, regularly fanned anaerobic microorganisms. They are omnipresent occupants of the gastrointestinal parcel, vagina and mouth (B. dentium) of warm blooded creatures, including people. Bifidobacteria are one of the significant genera of microscopic organisms that make up the gastrointestinal parcel microbiota in warm blooded creatures. Some bifidobacteria are utilized as probiotics. Bifidobacteria, called probiotics, are a characteristic piece of the bacterial verdure in the human body and have a harmonious microbes have relationship with people. B. longum advances great assimilation, supports the invulnerable framework, and produces lactic and acidic corrosive that controls intestinal pH. These microorganisms likewise repress the development of Candida albicans, E. coli, and different microorganisms that have more pathogenic characteristics than Bifidobacteria.Members of the family Bifidobacterium are among the principal organisms to colonize the human gastrointestinal lot and are accepted to apply positive medical advantages on their host. Because of their implied wellbeing advancing properties, bifidobacteria have been joined into numerous utilitarian food varieties as dynamic fixings. Bifidobacteria normally happen in a scope of natural specialties that are either straightforwardly or by implication associated with the creature gastrointestinal plot, like the human oral depression, the creepy crawly gut and sewage.

The intestinal microbiota has progressively been displayed to play an indispensable part in different parts of human wellbeing. Surely, a few examinations have connected adjustments in the gut microbiota with the improvement of various infections. Among the immense gut bacterial local area, Bifidobacterium is a sort which rules the digestive system of sound bosom took care of newborn children while in adulthood the levels are lower yet generally steady. The presence of various types of bifidobacteria changes with age, from youth to advanced age. Bifidobacterium longum, B. breve, and B. bifidum are for the most part predominant in newborn children, though B. catenulatum, B. adolescentis and, just as B. longum are more common in grown-ups.

The intestinal microbiota assumes a significant part in human wellbeing and has for some time been related with so much capacities as metabolic, defensive, and trophic (Guarner and Malagelada, 2003) and all the more as of late capacities identified with the gut-mind hub or liver-gut pivot (Clarke et al., 2014). The current dramatic expansion in sequencing and the blast of other "omics" approaches has permitted us to acquire a profound information on intestinal microbiota.


Like other probiotic microscopic organisms, B. bifidum can be created outside your body and ingested orally. Certain food sources are plentiful in it, including:

• yogurt with added societies

• kefir, an aged milk drink

• buttermilk

• fermented food sources including kimchi, tempeh, miso, and pickles

• cured meats

• certain wines

• sauerkraut

• sourdough bread

• some vinegars

Significance in Human Body

Improving invulnerability

A few investigations on human tissue cells show that B. bifidum may further develop resistance. Scientists in one study Trusted Source noticed that various strains of these microorganisms can impact the safe framework. Some can support insusceptibility by enrolling white platelets to fend off a contamination. Others can diminish irritation by enrolling less white platelets. More clinical preliminaries on human subjects are expected to assess the worth of B. bifidum on the safe framework.

Bifidobacteria and the new born child gut

The human new born child gut is moderately clean up until birth, where it takes up microscopic organisms from its general climate and its mother. The micro biota that makes up the baby gut varies from the grown-up gut. A new born child arrives at the grown-up phase of their micro biome at around 3 years old, when their micro biome variety increments, settles, and the baby switches over to strong food sources. Bosom took care of, new born children are colonized before by Bifidobacterium when contrasted with infants that are fundamentally equation fed. Bifidobacterium is the most widely recognized microscopic organisms in the baby gut microbiome. There is greater fluctuation in genotypes over the long haul in babies, making them less steady contrasted with the grown-up Bifidobacterium. Babies and youngsters under 3 years of age show low variety in microbiome microorganisms, yet greater variety between people when contrasted with adults. Reduction of Bifidobacterium and expansion in variety of the newborn child gut microbiome happens with less bosom milk admission and increment of strong food consumption. Mammalian milk all contain oligosaccharides showing normal selection[clarification needed]. Human milk oligosaccharides are not processed by catalysts and stay entire through the stomach related lot prior to being separated in the colon by microbiota. Bifidobacterium species genomes of B. longum, B. bifidum, B. breve contain qualities that can hydrolyze a portion of the human milk oligosaccharides and these are found in higher numbers in newborn children that are bosom taken care of. Glycans that are created by the people are changed over into food and energy for the B. bifidum. showing an illustration of coevolution.



1. Fukiya S, Suzuki T, Kano Y, et al. Lactic acid bacteria and bifidobacteria: current progress in advanced research. 2011;65:33-51.

2. Lederberg J, Tatum EL. Gene recombination in Escherichia coli. Nature. 1946;158(4016):558-62.

3. Le Leu RK, Hu Y, Brown IL, et al. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 2010 ;31(2):246-51.

4. Mayo B, Van Sinderen D, editors. Bifidobacteria: genomics and molecular aspects. Hori Sci Pre. 2010.

5. Maguin E, Duwat P, Hege T, Ehrlich D, Gruss A. New thermosensitive plasmid for gram-positive bacteria. J bacterioi. 1992 ;174(17):5633-8.

Get the App